NeuroMetrix Inc (NURO) · This report is a licensed product and is not to be copied, reproduced,...

NeuroMetrix Inc (NURO)

Medical Equipment - Deals and Alliances Profile

Report Code: GDME101D Published: July 2018

NeuroMetrix Inc (NURO) - Medical Equipment - Deals and Alliances Profile


© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form

Company Snapshot

Company Overview NeuroMetrix Inc (NeuroMetrix) is a medical device company that develops wearable medical technology and point of care test to manage chronic pain, nerve diseases, and sleep disorders. The company’s products include quell wearable pain relief device, SENSUS pain therapy device, NC-stat DPNCheck and advance NCS system. Its SENSUS pain therapy and NC-stat DPNCheck are used for the treatment of diabetic peripheral neuropathy. NeuroMetrix has expertise in basic and clinical neurophysiology, biomedical engineering and instrumentation, and information technology. The company caters to clinics, hospitals, managed care organizations, retail health businesses, and durable medical equipment suppliers.

Key Facts

NeuroMetrix Inc, Medical Equipment, Key Facts, 2016

Web Address Revenue (US$ million) Number of Employees GlobalData

Financial Deals Landscape NeuroMetrix Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018

Note: Deals include all announced medical equipment deals from 2012 onwards, GlobalData

NeuroMetrix Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018


NeuroMetrix Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018


NeuroMetrix Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018


NeuroMetrix Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018

Year No. of Deals Deal Value (US$ million)

2012

2013

2014

2015

2016

2017

YTD 2018

Note: Deals include all announced medical equipment deals from 2012 onwards, deal values included wherever disclosed, GlobalData




Table of Contents

Table of Contents ............................................................................................................................................................................... 3 List of Tables .................................................................................................................................................................................. 4 List of Figures ................................................................................................................................................................................ 4

NeuroMetrix Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 ......................................................................................... 5 NeuroMetrix Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 .......................................................................................... 6 NeuroMetrix Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 ...................................................................................... 7 NeuroMetrix Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 ..................................................................................... 8 NeuroMetrix Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 ...................................................................................... 9 NeuroMetrix Inc, Medical Equipment, Deal Details ........................................................................................................................ 10

Partnerships ................................................................................................................................................................................ 10 NeuroMetrix to Enter into Agreement with GlaxoSmithkline Consumer Healthcare ............................................................ 10 NeuroMetrix Enters into Agreement with Fukuda Denshi ..................................................................................................... 11 NeuroMetrix Enters into Agreement with Synovation Medical ............................................................................................. 12 NeuroMetrix Enters into Agreement with Scripps Translational Science Institute ................................................................ 13 NeuroMetrix Enters Into Distribution Agreement With DJO Global For Sensus Pain Management System ......................... 14 NeuroMetrix Enters Into Distribution Agreement With Omron Healthcare For NC-stat DPNCheck ..................................... 15 NeuroMetrix Enters Into Distribution Agreement With Omron Healthcare For NC-stat DPNCheck ..................................... 16 NeuroMetrix Enters Into Distribution Agreement With Handok Pharma For NC-stat DPNCheck ......................................... 17

Equity Offering ............................................................................................................................................................................ 18 NeuroMetrix Raises USD3.5 Million in Private Placement of First Tranche of Series F Preferred Stock ................................ 18 NeuroMetrix Plans to Raise Funds through Public Offering of Shares ................................................................................... 20 NeuroMetrix Raises USD4 Million in Private Placement of Series E Preferred Stock and Warrants ...................................... 21 NeuroMetrix Prices Public Offering of Shares for USD26.5 Million ....................................................................................... 23 NeuroMetrix Raises USD21.3 Million in Private Placement of Shares and Warrants ............................................................ 25 NeuroMetrix Raises USD13.8 Million in Private Placement of Shares and Warrants ............................................................ 26 NeuroMetrix Raises USD14.7 Million in Public Offering of Units ........................................................................................... 28 NeuroMetrix Raises USD8 Million in Private Placement of Securities ................................................................................... 30 NeuroMetrix Completes Private Placement Of Preferred Shares For US$5 Million .............................................................. 31 NeuroMetrix Completes Public Offering Of Units For US$8.5 Million ................................................................................... 32

Asset Transactions ...................................................................................................................................................................... 33 GSK Consumer Healthcare to Acquire Quell technology from NeuroMetrix for USD5 Million .............................................. 33

NeuroMetrix Inc - Key Competitors ................................................................................................................................................. 34 NeuroMetrix Inc - Key Employees.................................................................................................................................................... 35 NeuroMetrix Inc - Locations And Subsidiaries ................................................................................................................................. 36

Head Office.................................................................................................................................................................................. 36 Other Locations & Subsidiaries ................................................................................................................................................... 36 Joint Venture ............................................................................................................................................................................... 36

Recent Developments ...................................................................................................................................................................... 37 Appendix .......................................................................................................................................................................................... 38

Methodology ............................................................................................................................................................................... 38 About GlobalData ........................................................................................................................................................................ 38 Disclaimer .................................................................................................................................................................................... 38




List of Tables

NeuroMetrix Inc, Medical Equipment, Key Facts, 2016 ..................................................................................................................... 2 NeuroMetrix Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 ...................................................................................... 2 NeuroMetrix Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 ......................................................................................... 5 NeuroMetrix Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 .......................................................................................... 6 NeuroMetrix Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 ...................................................................................... 7 NeuroMetrix Inc, Deals By Market, 2012 to YTD 2018 ...................................................................................................................... 8 NeuroMetrix Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 ...................................................................................... 9 NeuroMetrix to Enter into Agreement with GlaxoSmithkline Consumer Healthcare ..................................................................... 10 NeuroMetrix Enters into Agreement with Fukuda Denshi .............................................................................................................. 11 NeuroMetrix Enters into Agreement with Synovation Medical ...................................................................................................... 12 NeuroMetrix Enters into Agreement with Scripps Translational Science Institute ......................................................................... 13 NeuroMetrix Enters Into Distribution Agreement With DJO Global For Sensus Pain Management System .................................. 14 NeuroMetrix Enters Into Distribution Agreement With Omron Healthcare For NC-stat DPNCheck ............................................... 15 NeuroMetrix Enters Into Distribution Agreement With Omron Healthcare For NC-stat DPNCheck ............................................... 16 NeuroMetrix Enters Into Distribution Agreement With Handok Pharma For NC-stat DPNCheck ................................................... 17 NeuroMetrix Raises USD3.5 Million in Private Placement of First Tranche of Series F Preferred Stock ......................................... 18 NeuroMetrix Plans to Raise Funds through Public Offering of Shares ............................................................................................ 20 NeuroMetrix Raises USD4 Million in Private Placement of Series E Preferred Stock and Warrants ............................................... 21 NeuroMetrix Prices Public Offering of Shares for USD26.5 Million ................................................................................................. 23 NeuroMetrix Raises USD21.3 Million in Private Placement of Shares and Warrants ...................................................................... 25 NeuroMetrix Raises USD13.8 Million in Private Placement of Shares and Warrants ...................................................................... 26 NeuroMetrix Raises USD14.7 Million in Public Offering of Units .................................................................................................... 28 NeuroMetrix Raises USD8 Million in Private Placement of Securities ............................................................................................. 30 NeuroMetrix Completes Private Placement Of Preferred Shares For US$5 Million ........................................................................ 31 NeuroMetrix Completes Public Offering Of Units For US$8.5 Million ............................................................................................. 32 GSK Consumer Healthcare to Acquire Quell technology from NeuroMetrix for USD5 Million ....................................................... 33 NeuroMetrix Inc, Key Competitors .................................................................................................................................................. 34 NeuroMetrix Inc, Key Employees ..................................................................................................................................................... 35 NeuroMetrix Inc, Joint Venture ....................................................................................................................................................... 36

List of Figures

NeuroMetrix Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 ......................................................................................... 2 NeuroMetrix Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 ......................................................................................... 2 NeuroMetrix Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 ...................................................................................... 2 NeuroMetrix Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 ..................................................................................... 2 NeuroMetrix Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 ......................................................................................... 5 NeuroMetrix Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 ......................................................................................... 6 NeuroMetrix Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 ...................................................................................... 7 NeuroMetrix Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 ..................................................................................... 8






Note: Deals include all announced medical equipment deals from 2012 onwards, deal values included wherever disclosed. GlobalData


Year No. of Deals Deal Value (US$ million)

2012

2013

2014

2015

2016

2017

YTD 2018

Note: Deals include all announced medical equipment deals from 2012 onwards, deal values included wherever disclosed. Above data is extracted from GlobalData’s Deals and Alliances Profile.

GlobalData




NeuroMetrix Inc, Medical Equipment Deals By Type, 2012 to YTD 2018

NeuroMetrix Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018

Note: Deals include all announced medical equipment deals from 2012 onwards GlobalData

NeuroMetrix Inc, Medical Equipment Deals By Type, 2012 to YTD 2018

Deal Type No. of Deals Deal Value (US$ million)









Region No. of Deals Deal Value (US$ million)





NeuroMetrix Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018

NeuroMetrix Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018


NeuroMetrix Inc, Deals By Market, 2012 to YTD 2018

Market No. of Deals Deal Value (US$ million)







Deal Date Deal Status Deal Type Acquirer (s) / Investor (s)

/Surviving Entity

Target / Issuer / Partner (s)

Vendor Deal Value (US$ m)

11-Jan-2018

11-Jan-2018

31-Oct-2017

08-Aug-2017

03-Aug-2017

05-Jan-2017

20-Dec-2016

22-Sep-2016

27-Jun-2016

08-Jun-2016

31-Dec-2015

29-May-2015

27-Jun-2014

04-Feb-2014

10-Dec-2013

07-Jun-2013

24-Apr-2013

12-Mar-2013

13-Feb-2012

Note: Deals include all medical equipment deals from 2012 onwards, deal values included wherever disclosed. GlobalData




NeuroMetrix Inc, Medical Equipment, Deal Details

Partnerships

NeuroMetrix to Enter into Agreement with GlaxoSmithkline Consumer Healthcare

NeuroMetrix to Enter into Agreement with GlaxoSmithkline Consumer Healthcare

Deal Type Deal Sub Type

Deal in Brief

Deal Rationale

Deal Information

Deal Status

Announced Date

Deal Financials

Deal Value (US$ m)

Companies Information

Partner Company Information

Company Name

Business Description

Company Name Parent


Advisor Information

Company Being Advised Financial Advisor

NeuroMetrix Inc GlobalData




NeuroMetrix Enters into Agreement with Fukuda Denshi

NeuroMetrix Enters into Agreement with Fukuda Denshi


Deal in Brief

Deal Rationale

Deal Information

Deal Status

Completed Date



Company Name


Company Name


GlobalData




NeuroMetrix Enters into Agreement with Synovation Medical

NeuroMetrix Enters into Agreement with Synovation Medical


Deal in Brief

Deal Rationale

Deal Information

Deal Status

Completed Date



Company Name


Company Name Synovation Medical Group GlobalData



© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form Page 34

NeuroMetrix Inc - Key Competitors

NeuroMetrix Inc, Key Competitors

Name Headquarters Revenue (US$ m)

Source: Annual Report, Company Website, Primary and Secondary Research GlobalData




NeuroMetrix Inc - Key Employees

NeuroMetrix Inc, Key Employees

Name Job Title Board Level Since Age





NeuroMetrix Inc - Locations And Subsidiaries

Head Office

NeuroMetrix Inc

1000 Winter Street

Waltham

MA

02451

United States

Tel: +1 781 8909989

Other Locations & Subsidiaries

Joint Venture

NeuroMetrix Inc, Joint Venture





Recent Developments




Appendix

The data and analysis within this report is driven by GlobalData.

GlobalData gives you the key information to drive sales, investment and deal making activity in your business.

Our coverage includes 200,000 + reports on 185,000+ companies (including 150,000+ private) across 200+ countries and 29 industries. The key industries include Alternative Energy, Oil & Gas, Clean Technology, Technology and Telecommunication, Pharmaceutical and Healthcare, Power, Financial Services, Chemical and Metal & Mining.

Methodology

GlobalData company reports are based on a core set of research techniques which ensure the best possible level of quality and accuracy of data. The key sources used include:

• Company Websites

• Company Annual Reports

• SEC Filings

• Press Releases

• Proprietary Databases

Notes

• Financial information for the company is taken from the most recently published annual reports or SEC filings

• The financial and operational data reported for the company is as per the industry defined standards

• Currencies are converted at current rates, with average annual rates taken for historic conversions

Deals includes all announced deals from 2011 onwards, deal values are included wherever disclosed.

About GlobalData

GlobalData is one of the world’s leading providers of company operational data and strategic analysis, providing detailed information on tens of thousands of companies globally. Our highly qualified team of Analysts, Researchers, and Solution Consultants use proprietary data sources and various tools and techniques to gather, analyze and represent the latest and the most reliable information essential for businesses to sustain a competitive edge. Data is continuously updated and revised by large teams of research experts, so that it always reflects the latest events and information. With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research material for this series and its other reports. GlobalData offers comprehensive geographic coverage across world’s most important sectors, focusing particularly on energy and healthcare.

Disclaimer

All Rights Reserved No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form by any means, electronic, mechanical, photocopying, recording or otherwise, without the prior permission of the publisher, GlobalData

NeuroMetrix Inc (NURO) · This report is a licensed product and is not to be copied, reproduced,...

Documents

Transcript of NeuroMetrix Inc (NURO) · This report is a licensed product and is not to be copied, reproduced,...